The CDKN1A was less downregulated in more advanced and aggressive cancers as it is positively correlated with TNM stage, primary tumor extension, and histopathological grade, and tended to be upregulated in tumors with distant metastases present. This evidence concerns the gene CDKN1A and cancer.